Citadel Advisors
NBP

Citadel Advisors’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Citadel Advisors’s Portfolio NBP Stock Details NBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10,000
Closed -$39.8K – 13567
2025
Q4 		$39.8K Sell
10,000
-400
-4% -$1.77K ﹤0.01% 12137
2025
Q3 		$39.3K Buy
10,400
+200
+2% +$679 ﹤0.01% 12302
2025
Q2 		$24.7K Sell
10,200
-9,800
-49% -$13.3K ﹤0.01% 12056
2025
Q1 		$16.5K Buy
+20,000
New +$19K ﹤0.01% 13280
2024
Q4 		– Sell
-56,400
Closed -$69.9K – 14909
2024
Q3 		$69.9K Buy
56,400
+53,400
+1,780% +$66.9K ﹤0.01% 11559
2024
Q2 		$5.01K Sell
3,000
-8,900
-75% -$15.9K ﹤0.01% 13437
2024
Q1 		$22.1K Buy
11,900
+11,400
+2,280% +$21K ﹤0.01% 12941
2023
Q4 		$950 Sell
500
-7,900
-94% -$11.8K ﹤0.01% 13913
2023
Q3 		$11.1K Sell
8,400
-1,300
-13% -$2.85K ﹤0.01% 13027
2023
Q2 		$29K Sell
9,700
-2,800
-22% -$8.99K ﹤0.01% 12390
2023
Q1 		$43.3K Sell
12,500
-5,600
-31% -$27.1K ﹤0.01% 12350
2022
Q4 		$75.7K Buy
18,100
+7,200
+66% +$27.3K ﹤0.01% 11593
2022
Q3 		$44K Sell
10,900
-11,800
-52% -$89.5K ﹤0.01% 11719
2022
Q2 		$257K Sell
22,700
-50,800
-69% -$609K ﹤0.01% 10161
2022
Q1 		$1.19M Buy
73,500
+62,900
+593% +$1.61M ﹤0.01% 7299
2021
Q4 		$502K Buy
10,600
+400
+4% +$24K ﹤0.01% 9687
2021
Q3 		$739K Sell
10,200
-1,800
-15% -$130K ﹤0.01% 8918
2021
Q2 		$1.01M Buy
+12,000
New +$792K ﹤0.01% 8358

Other funds holding NBP

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
ACM
AIHC Capital Management Central $120M AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Citadel Advisors's NBP Position: Q1 2026 in Review

Citadel Advisors opened a new position in NovaBridge Biosciences American Depositary Shares (NBP) in Q1 2026: 166,616 shares worth $410K. The stake represents ﹤0.01% of the portfolio and ranks #9765 among its holdings. This is a return to the name: Citadel Advisors previously reported a position in NBP as recently as Q4 2024.

Citadel Advisors first reported a position in NBP in Q4 2020 and has held it in 15 quarters since. The position peaked at $3.63M in Q4 2020. 48 funds tracked by Wall St. Rank hold NBP as of Q1 2026.

  • Citadel Advisors held 166,616 shares of NovaBridge Biosciences American Depositary Shares worth $410K as of Q1 2026.
  • NovaBridge Biosciences American Depositary Shares was a new Citadel Advisors position in Q1 2026.
  • NovaBridge Biosciences American Depositary Shares made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #9765 holding.
  • Citadel Advisors first reported a position in NovaBridge Biosciences American Depositary Shares in Q4 2020 and has held it in 15 quarters since.
  • Citadel Advisors's NovaBridge Biosciences American Depositary Shares position peaked at $3.63M in Q4 2020.
  • 48 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.